These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9916251)
81. Beta-KTx14.3, a scorpion toxin, blocks the human potassium channel KCNQ1. Titaux-Delgado G; Lopez-Giraldo AE; Carrillo E; Cofas-Vargas LF; Carranza LE; López-Vera E; García-Hernández E; Del Rio-Portilla F Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140906. PubMed ID: 36918120 [TBL] [Abstract][Full Text] [Related]
82. 1H NMR structural analysis of novel potassium blocking toxins using a nano-NMR probe. Delepierre M; Prochnicka-Chalufour A; Possani LD Toxicon; 1998 Nov; 36(11):1599-608. PubMed ID: 9792176 [TBL] [Abstract][Full Text] [Related]
83. Kv1.3 potassium channel-blocking toxin Ctri9577, novel gating modifier of Kv4.3 potassium channel from the scorpion toxin family. Xie C; Li T; Xu L; Yu C; Cao Z; Li W; Wu Y Biochem Biophys Res Commun; 2014 Feb; 444(3):406-10. PubMed ID: 24472546 [TBL] [Abstract][Full Text] [Related]
84. Ts8 scorpion toxin inhibits the Kv4.2 channel and produces nociception in vivo. Pucca MB; Cerni FA; Cordeiro FA; Peigneur S; Cunha TM; Tytgat J; Arantes EC Toxicon; 2016 Sep; 119():244-52. PubMed ID: 27346450 [TBL] [Abstract][Full Text] [Related]
85. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Swartz KJ; MacKinnon R Neuron; 1995 Oct; 15(4):941-9. PubMed ID: 7576642 [TBL] [Abstract][Full Text] [Related]
86. Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K Qin C; Wan X; Li S; Yang F; Yang L; Zuo Z; Cao Z; Chen Z; Wu Y Int J Biol Macromol; 2021 May; 178():143-153. PubMed ID: 33636268 [TBL] [Abstract][Full Text] [Related]
87. Synthesis by native chemical ligation and characterization of the scorpion toxin AmmTx3. Zoukimian C; Meudal H; De Waard S; Ouares KA; Nicolas S; Canepari M; Béroud R; Landon C; De Waard M; Boturyn D Bioorg Med Chem; 2019 Jan; 27(1):247-253. PubMed ID: 30529150 [TBL] [Abstract][Full Text] [Related]
95. Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K+ channel, SkCa2. Shakkottai VG; Regaya I; Wulff H; Fajloun Z; Tomita H; Fathallah M; Cahalan MD; Gargus JJ; Sabatier JM; Chandy KG J Biol Chem; 2001 Nov; 276(46):43145-51. PubMed ID: 11527975 [TBL] [Abstract][Full Text] [Related]
96. Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms. Diego-García E; Abdel-Mottaleb Y; Schwartz EF; de la Vega RC; Tytgat J; Possani LD Cell Mol Life Sci; 2008 Jan; 65(1):187-200. PubMed ID: 18030427 [TBL] [Abstract][Full Text] [Related]
97. An emerging pharmacology of peptide toxins targeted against potassium channels. Moczydlowski E; Lucchesi K; Ravindran A J Membr Biol; 1988 Oct; 105(2):95-111. PubMed ID: 2464066 [TBL] [Abstract][Full Text] [Related]
98. Bioinformatic characterizations and prediction of K+ and Na+ ion channels effector toxins. Soli R; Kaabi B; Barhoumi M; El-Ayeb M; Srairi-Abid N BMC Pharmacol; 2009 Mar; 9():4. PubMed ID: 19284552 [TBL] [Abstract][Full Text] [Related]
99. A Molecular Lid Mechanism of K Saikia C; Dym O; Altman-Gueta H; Gordon D; Reuveny E; Karbat I J Mol Biol; 2021 Aug; 433(17):166957. PubMed ID: 33771569 [TBL] [Abstract][Full Text] [Related]